Corporate Information | Press & Media | For Investors

ThinkGenetic

ThinkGenetic

Finding Patients At Risk for Rare Disease

  • Home
  • Solutions
    • FindEHR™
    • FindSM™
  • Research
    • Medical Publications
    • Technical Research
  • About
    • Team
    • Board
    • Partners
  • News & Events
  • Contact
  • Request a Demo

[Press Release] Ochsner Lafayette Healthcare Innovation Fund Invests in ThinkGenetic Vision for Genetic Disease Identification in Local Patients

By Ruth O'Keefe, Apr 20, 2021

Innovation Fund Investment - ThinkGenetic

LAFAYETTE, La., April 20, 2021 (Newswire.com) – Today ThinkGenetic, Inc. (thinkgenetic.com) announces the official acceptance of a $500,000 investment from the Ochsner Lafayette General Healthcare Innovation Fund.

“After years of working with healthcare partners in the area and participating in the Accelerate South program,” says ThinkGenetic CEO Dave Jacob. “ThinkGenetic is thrilled to be officially establishing our Lafayette office to bring greater awareness and education about genetic conditions to the community in 2021. Through this office we will continue to build important relationships with the local healthcare systems, advocacy groups, and providers.”

The Healthcare Innovation Fund II (HIF II) is a corporate venture fund that supports emerging companies driving transformation and innovation in health care. HIF II’s approach is highly collaborative with a mission to catalyze fundamental transformation in US healthcare through investments in companies that are delivering transformative and innovative solutions in patient care and experience, value based payments, back office automation, and data coupled with deep learning.

“ThinkGenetic’s SymptomMatcher solution check’s all of our mission boxes,” said Mike Dozier, VP/CIO at Ochsner Lafayette General. “By identifying undiagnosed patients with rare genetic conditions via algorithmic analysis of health record data, their solution improves the patient experience, and allows the health system to reach out and direct patients to the right care, to the right person at the right time.”

Expanding its relationship with the Lafayette community, ThinkGenetic has established its regional headquarters in the city and plans to utilize the additional resources to finish building out its specialized algorithms for identifying potential patients with underlying genetic disorders based on specific health care record data points. ThinkGenetic plans to use the funds to expand its range of services and personnel, create new partnerships and develop new cutting-edge technology to complement current offerings. In addition, the new relationship with Ochsner Lafayette General will bring new services to Louisiana including clinical trials and electronic medical record reviews.

To stay up to date on the latest business developments of ThinkGenetic and the company’s progress in Lafayette, please visit https://www.thinkgenetic.com/news or follow on social media using @ThinkGeneticInc.

Download Press Release (PDF)

About Ruth O’Keefe

Ruth anticipates and manages ThinkGenetic's marketing needs in a dynamic environment. She maintains strong engagement with clients and healthcare providers to further the ThinkGenetic mission.

Investor News, News, Press Releases artificial intelligence, Dave Jacob, genetic disease, Healthcare Innovation Fund, Lafayette, Lafayette General Health Systems, machine learning, Ochsner, Ochsner Lafayette General, Rare Disease, SymptomMatcher, ThinkGenetic

Upcoming Events

Sep 20
September 20 - September 24

Fabry Family Education Conference and Camp 2023

Oct 17
October 17 - October 21

NSGC Annual Conference 2023

Feb 4
February 4, 2024 - February 9, 2024

WORLDSymposium on Lysosomal Disease Research 2024

Mar 12
March 12, 2024 - March 16, 2024

ACMG Annual Clinical Genetics Meeting 2024

Feb 2
February 2, 2025 - February 7, 2025

WORLDSymposium on Lysosomal Disease Research 2025

View Calendar

Together let’s systematically accelerate detecting at-risk  individuals.

Request a Demo

  • Solutions
    • FindEHR™
    • FindSM™
  • Resources
    • Contact
    • Research
    • FAQs
  • About ThinkGenetic
    • Team
    • Board
    • Investors
    • Careers
  • Legal
    • Disclaimers
    • Privacy Policy

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube

ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information.

©2023 ThinkGenetic. All Rights Reserved.